Le Lézard
Classified in: Health
Subjects: CHI, RCL, PSF, CFG, DEI

Advisory - Certain lots of L'il Critters and vitafusion vitamins recalled due to metal wire fragments


OTTAWA, ON, April 20, 2021 /CNW/ -

Summary

Issue
Church & Dwight Canada Corp. is recalling certain lots of L'il Critters Gummy Vites children's vitamins, as well as vitafusion Fibre Well and vitafusion MultiVites vitamins for adults, because certain lots may contain metal wire fragments. The affected lots were manufactured within a specific four-day period between October 29 and November 3, 2020. The products were distributed nationally.

Ingesting the metal fragment could damage the digestive system. Based on information from the company, the metal fragments are thought to be small pieces of a stainless steel filter screen that failed during manufacturing. The fragments are thin, visible, flexible wires measuring approximately 25 millimetres long. The company became aware after receiving consumer complaints, none of which involved a report of consumer injury as a result of the issue.

Health Canada is monitoring the effectiveness of the recall and the company's implementation of any necessary corrective and preventative actions. Should any additional recalls be deemed necessary, Health Canada will update the table below and inform Canadians.

Affected products

Product

NPN

Product UPC

Lot

Expiry

L'il Critters Gummy Vites

70-count bottle

80093799

 

0-27917-27000-5

WA03063552

WA03101954

05/2022

L'il Critters Gummy Vites

190-count bottle

80093799

0-27917-01704-4

 

WA03105933

WA03105561

05/2022

02/2022

L'il Critters Gummy Vites

275-count bottle

80093799

0-27917-00198-2

 

WA03066312

WA03065947

05/2022

vitafusion Fibre Well

90-count bottle

80046319

 

0-27917-02298-7

WA03086272

11/2022

vitafusion MultiVites

250-count bottle

80089431

0-27917-00197-5

WA03045979

WA03045978

04/2022

vitafusion MultiVites

150-count bottle

80089431

0-27917-02333-5

WA03046274

04/2022

 

What you should do

Également disponible en français

SOURCE Health Canada


These press releases may also interest you

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...

at 02:00
In response to the increasing complexities of the aging journey and the rising trend of...

at 02:00
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...

at 01:24
Sedana Medical AB (publ) announces that all 235 randomized patients have been recruited for its INSPiRE-ICU 1 phase III clinical trial in the United States. Concurrently, the identical INSPiRE-ICU 2 trial is nearing completion, with 23 of 235...



News published on and distributed by: